Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Vanesa Zylberman"'
Autor:
Diego H. Farizano Salazar, Fernando Achinelli, Mariana Colonna, Lucía Pérez, Analía A. Giménez, Maria Alejandra Ojeda, Susana N. Miranda Puente, Lía Sánchez Negrette, Florencia Cañete, Ornela I. Martelotte Ibarra, Santiago Sanguineti, Linus Spatz, Fernando A. Goldbaum, Carolina Massa, Marta Rivas, Mariana Pichel, Yanina Hiriart, Vanesa Zylberman, Sandra Gallego, Brenda Konigheim, Francisco Fernández, Matías Deprati, Ian Roubicek, Diego H. Giunta, Esteban Nannini, Gustavo Lopardo, Waldo H. Belloso
Publikováno v:
PLoS ONE, Vol 17, Iss 9 (2022)
Background Passive immunotherapy has been evaluated as a therapeutic alternative for patients with COVID-19 disease. Equine polyclonal immunotherapy for COVID-19 (EPIC) showed adequate safety and potential efficacy in a clinical trial setting and obt
Externí odkaz:
https://doaj.org/article/4363a6c2fd5140d3a83b6c5248f4ac56
Autor:
Gustavo Lopardo, Waldo H. Belloso, Esteban Nannini, Mariana Colonna, Santiago Sanguineti, Vanesa Zylberman, Luciana Muñoz, Martín Dobarro, Gabriel Lebersztein, Javier Farina, Gabriela Vidiella, Anselmo Bertetti, Favio Crudo, Maria Fernanda Alzogaray, Laura Barcelona, Ricardo Teijeiro, Sandra Lambert, Darío Scublinsky, Marisa Iacono, Vanina Stanek, Rubén Solari, Pablo Cruz, Marcelo Martín Casas, Lorena Abusamra, Héctor Lucas Luciardi, Alberto Cremona, Diego Caruso, Bernardo de Miguel, Santiago Perez Lloret, Susana Millán, Yael Kilstein, Ana Pereiro, Omar Sued, Pedro Cahn, Linus Spatz, Fernando Goldbaum
Publikováno v:
EClinicalMedicine, Vol 34, Iss , Pp 100843- (2021)
Background: passive immunotherapy is a therapeutic alternative for patients with COVID-19. Equine polyclonal antibodies (EpAbs) could represent a source of scalable neutralizing antibodies against SARS-CoV-2. Methods: we conducted a double-blind, ran
Externí odkaz:
https://doaj.org/article/ec820ba9ff694b43a46be21dcfe640dc
Autor:
Nicolas Torres, María Victoria Regge, Florencia Secchiari, Adrián David Friedrich, Raúl Germán Spallanzani, Ximena Lucía Raffo Iraolagoitia, Sol Yanel Núñez, Jessica Mariel Sierra, Andrea Ziblat, María Cecilia Santilli, Nicolás Gilio, Evangelina Almada, Constanza Lauche, Romina Pardo, Carolina Inés Domaica, Mercedes Beatriz Fuertes, Kevin Patrick Madauss, Israel S Gloger, Vanesa Zylberman, Fernando Alberto Goldbaum, Norberto Walter Zwirner
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Background Natural killer and cytotoxic CD8+ T cells are major players during antitumor immunity. They express NKG2D, an activating receptor that promotes tumor elimination through recognition of the MHC class I chain-related proteins A and B (MICA a
Externí odkaz:
https://doaj.org/article/60794d6d6f5348769085d3ffeeb174f9
Autor:
Hernán Ruy Bonomi, María Inés Marchesini, Sebastián Klinke, Juan E Ugalde, Vanesa Zylberman, Rodolfo A Ugalde, Diego J Comerci, Fernando Alberto Goldbaum
Publikováno v:
PLoS ONE, Vol 5, Iss 2, p e9435 (2010)
Brucellosis is a worldwide zoonosis that affects livestock and humans and is caused by closely related Brucella spp., which are adapted to intracellular life within cells of a large variety of mammals. Brucella can be considered a furtive pathogen th
Externí odkaz:
https://doaj.org/article/febe168483454eed8a8ab6fc5c71022e
Autor:
María Celeste, Moran, María Paula, Dominguez, Angel Ricardo, Bence, Marcelo Gastón, Rodriguez, Fernando Alberto, Goldbaum, Vanesa, Zylberman, Pardo Romina, Paola, Giuliana, Lupi, Ivan Sergio, Marcipar, Claudia María, Lützelschwab, Silvia Marcela, Estein
Publikováno v:
Research in Veterinary Science. 145:29-39
Brucella ovis is an economically important cause of epididymitis in rams worldwide. Polymeric BLSOmp31 was previously identified as a protective immunogen against this pathogen. In this study, BLSOmp31 was formulated with a modified version of ISCOMA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78f827bb7ab357d3332ca9bb5b1bef2a
https://doi.org/10.1016/j.rvsc.2022.02.001
https://doi.org/10.1016/j.rvsc.2022.02.001
Autor:
Matías R. Iglesias Rando, Natalia Gorojovsky, Vanesa Zylberman, Fernando A. Goldbaum, Patricio O. Craig
Publikováno v:
Applied Microbiology and Biotechnology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f47fd749479b46c83c9a92b1797943d
https://doi.org/10.1007/s00253-023-12581-6
https://doi.org/10.1007/s00253-023-12581-6
Autor:
María F. Sánchez Vallecillo, María Celeste Moran, Vanesa Zylberman, Belkys A. Maletto, Marcelo Rodriguez, Santiago Daniel Palma, Fernando Alberto Goldbaum, Romina Paola Pardo, Angel Ricardo Bence, Claudia María Lützelschwab, Silvia M. Estein
Publikováno v:
Research in Veterinary Science. 135:217-227
Previously, we demonstrated that the chimera BLSOmp31 formulated in chitosan microspheres or Poloxamer407-Chitosan administered via the nasal and the ocular mucosa conferred partial protection in sheep against B. ovis. In this work, we tested a new d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd2b5a1315873c130964cd763c350319
https://doi.org/10.1016/j.rvsc.2021.02.011
https://doi.org/10.1016/j.rvsc.2021.02.011
Autor:
Gonzalo Santiago, Yanina Hiriart, Luciana Muñoz, Florencia Rey, Gustavo Hein, Santiago Sanguineti, Vanesa Zylberman, Hugo Ortega, Belkis Marelli
Hemolytic uremic syndrome associated to Shiga-toxin produced by Escherichia coli is a serious worldwide foodborne disease. Nowadays, no treatment is available, only supportive care can be provided, and 50 % of the patients require a period of dialysi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a6a9a821370f93fd9932c6431288187
https://doi.org/10.22541/au.164864215.51639919/v1
https://doi.org/10.22541/au.164864215.51639919/v1
Autor:
Fernando A. Goldbaum, Vanesa Zylberman, Santiago Daniel Palma, María Clausse, Alejandra Graciela Díaz, Romina Paola Pardo, Daniela Alejandra Quinteros, Fernando Paolicchi, Mariana Alejandra Rivero, Silvia Marcela Estein
Publikováno v:
Veterinary Immunology and Immunopathology. 209:70-77
Subcellular vaccines against ovine contagious epididymitis due Brucella ovis can solve some shortcomings associated with the use of Brucella melitensis Rev 1. We have demonstrated that the parenteral immunization with polymeric antigen BLSOmp31 emuls
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1e488eb23854b61a6febda4e953709d
https://doi.org/10.1016/j.vetimm.2019.02.005
https://doi.org/10.1016/j.vetimm.2019.02.005
Autor:
Fernando Alberto Goldbaum, Belkis Ester Marelli, Luciana Muñoz, Ulises Sebastián Notaro, Santiago Sanguineti, Paula Silvestrini, Hugo Hector Ortega, Facundo José Salinas, Lucas Etchevers, Vanesa Zylberman, Natalia Raquel Salvetti
Publikováno v:
Toxicology and Applied Pharmacology
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has required the urgent development of new therapies, among which passive immunotherapy is contemplated. CoviFab (INM005) is a RBD-specific F(ab′)2 fragment derived from equine polycl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d4da52b726140e73a0a66f14b19edb3
https://pubmed.ncbi.nlm.nih.gov/34785274
https://pubmed.ncbi.nlm.nih.gov/34785274